BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26241027)

  • 1. Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.
    Saxena A; Russo I; Frangogiannis NG
    Transl Res; 2016 Jan; 167(1):152-66. PubMed ID: 26241027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.
    Prabhu SD; Frangogiannis NG
    Circ Res; 2016 Jun; 119(1):91-112. PubMed ID: 27340270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.
    Huang S; Frangogiannis NG
    Br J Pharmacol; 2018 May; 175(9):1377-1400. PubMed ID: 29394499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblasts in myocardial infarction: a role in inflammation and repair.
    Shinde AV; Frangogiannis NG
    J Mol Cell Cardiol; 2014 May; 70():74-82. PubMed ID: 24321195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction.
    Seropian IM; Toldo S; Van Tassell BW; Abbate A
    J Am Coll Cardiol; 2014 Apr; 63(16):1593-603. PubMed ID: 24530674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the chemokines in cardiac repair.
    Cavalera M; Frangogiannis NG
    Curr Pharm Des; 2014; 20(12):1971-9. PubMed ID: 23844733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational concepts.
    Frangogiannis NG
    Discoveries (Craiova); 2015; 3(1):. PubMed ID: 26273700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory response in myocardial infarction.
    Frangogiannis NG; Smith CW; Entman ML
    Cardiovasc Res; 2002 Jan; 53(1):31-47. PubMed ID: 11744011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymol attenuates inflammation in isoproterenol induced myocardial infarcted rats by inhibiting the release of lysosomal enzymes and downregulating the expressions of proinflammatory cytokines.
    Nagoor Meeran MF; Jagadeesh GS; Selvaraj P
    Eur J Pharmacol; 2015 May; 754():153-61. PubMed ID: 25724787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities.
    Hilgendorf I; Frantz S; Frangogiannis NG
    Circ Res; 2024 Jun; 134(12):1718-1751. PubMed ID: 38843294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inflammatory response and cardiac repair after myocardial infarction.
    Nah DY; Rhee MY
    Korean Circ J; 2009 Oct; 39(10):393-8. PubMed ID: 19949583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune system and cardiac repair.
    Frangogiannis NG
    Pharmacol Res; 2008 Aug; 58(2):88-111. PubMed ID: 18620057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities.
    Frangogiannis NG
    J Cardiovasc Pharmacol; 2014 Mar; 63(3):185-95. PubMed ID: 24072174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune cells in repair of the infarcted myocardium.
    Chen B; Frangogiannis NG
    Microcirculation; 2017 Jan; 24(1):. PubMed ID: 27542099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation in cardiac injury, repair and regeneration.
    Frangogiannis NG
    Curr Opin Cardiol; 2015 May; 30(3):240-5. PubMed ID: 25807226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy.
    Thiele JR; Habersberger J; Braig D; Schmidt Y; Goerendt K; Maurer V; Bannasch H; Scheichl A; Woollard KJ; von Dobschütz E; Kolodgie F; Virmani R; Stark GB; Peter K; Eisenhardt SU
    Circulation; 2014 Jul; 130(1):35-50. PubMed ID: 24982116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines in Myocardial Infarction.
    Chen B; Frangogiannis NG
    J Cardiovasc Transl Res; 2021 Feb; 14(1):35-52. PubMed ID: 32415537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanistic basis of infarct healing.
    Frangogiannis NG
    Antioxid Redox Signal; 2006; 8(11-12):1907-39. PubMed ID: 17034340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory mechanisms in myocardial infarction.
    Ren G; Dewald O; Frangogiannis NG
    Curr Drug Targets Inflamm Allergy; 2003 Sep; 2(3):242-56. PubMed ID: 14561159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.
    Tourki B; Halade G
    FASEB J; 2017 Oct; 31(10):4226-4239. PubMed ID: 28642328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.